Original Research

Corrective Cosmetics Are Effective for Women With Facial Pigmentary Disorders

Author and Disclosure Information

Visible facial lesions are a common and burdensome skin problem. This study examines the impact of corrective cosmetics in women with severe facial pigmentary disorders. Enrollment consisted of 73 women with one or more of the following conditions: acne, dermatosis papulosis, hypopigmentation, lentigines, melasma, rosacea, vascular proliferations, or other facial scars. The corrective cosmetic (Dermablend®) was applied at the initial visit, at which time instructions and a supply of product were provided. Assessments were conducted at baseline, 2-week, 4-week, and 3-month follow-up visits on 63 patients using the Skindex-16. The corrective cosmetic was well tolerated. There was improvement in Skindex-16 scores after application of the corrective cosmetic, which continued at each follow-up visit and after adjustment for baseline confounders using multiple regression analyses. At 3 months, there was a 30% improvement in Skindex-16 score (P.001). The corrective cosmetic was well tolerated and represents a valuable option that dermatologists can offer to patients with these conditions.


 

Recommended Reading

Large Solitary Café au Lait Spots: A Report of 5 Cases and Review of the Literature
MDedge Dermatology
Evaluation of Inherent Differences Between African American and White Skin Surface Properties Using Subjective and Objective Measures
MDedge Dermatology
A Double-Blind Comparative Study of Sodium Sulfacetamide Lotion 10% Versus Selenium Sulfide Lotion 2.5% in the Treatment of Pityriasis (Tinea) Versicolor
MDedge Dermatology
Over-the-Counter Topical Skin Products—A Common Component of Skin Disease Management
MDedge Dermatology
Hyperpigmented Scar Due to Minocycline Therapy
MDedge Dermatology
Mequinol 2%/Tretinoin 0.01% Solution: An Effective and Safe Alternative to Hydroquinone 3% in the Treatment of Solar Lentigines
MDedge Dermatology
A Microsponge Formulation of Hydroquinone 4% and Retinol 0.15% in the Treatment of Melasma and Postinflammatory Hyperpigmentation
MDedge Dermatology
Hydroquinone 4%, Tretinoin 0.05%, Fluocinolone Acetonide 0.01%: A Safe and Efficacious 12-Month Treatment for Melasma
MDedge Dermatology
Cutaneous Hyperpigmentation Due to Chronic Quinine Ingestion
MDedge Dermatology
Linear Congenital Becker Nevus
MDedge Dermatology